Carregant...
Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
SUMMARY: This retrospective study reports 81% long-term (> 3 years) adherence to and 77% persistence with zoledronic acid (ZA) treatment in osteoporosis patients, with ZA being costfree for patients. Eight percent of patients discontinued treatment because of adverse events (AEs), with a tendency...
Guardat en:
| Publicat a: | Arch Osteoporos |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer London
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165128/ https://ncbi.nlm.nih.gov/pubmed/32303862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11657-020-00733-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|